360dx4h
Sera Prognostics Q3 Revenues Drop 31 Percent, Firm Begins Consumer-Initiated Preterm Birth Testing
The firm said on Wednesday that it has been hiring key sales and marketing personnel as it prepares to ramp up sales in 2025 of its PreTRM proteomic test.
360dx13h
Siemens Healthineers Reports Leaner, More Profitable Dx Business Poised for Growth Amid Transformation
The firm reported that its adjusted diagnostics revenues rose less than 1 percent, excluding the COVID-19 rapid antigen testing business that the firm exited last year.
360dx15h
Caris Life Sciences CDx Assay Nabs FDA Approval
The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.
360dx16h
Siemens Healthineers Revenues Rise 5 Percent
The firm reported that its adjusted diagnostics revenues rose less than 1 percent, excluding the COVID-19 rapid antigen testing business that the firm exited last year.